Evidence map›Paper›PMID 37542245›Full record

ReviewJournal of nanobiotechnology2023

Metallic nanoplatforms for COVID-19 diagnostics: versatile applications in the pandemic and post-pandemic era.

Yuqing Li, Jingqi Chen, Jinchao Wei, Xueliang Liu, Lu Yu, Linqi Yu, Ding Ding, Yu Yang

Open access · goldAbstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yuqing Li *Institute of Molecular Medicine (IMM), School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China.
Jingqi Chen *Institute of Molecular Medicine (IMM), School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China.
Jinchao WeiState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Xueliang LiuInstitute of Molecular Medicine (IMM), School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China.
Lu YuInstitute of Molecular Medicine (IMM), School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China.
Linqi YuDepartment of Immunization Program, Jing'an District Center for Disease Control and Prevention, Shanghai, 200072, China. yulinqi@jingancdc.net.
Ding DingInstitute of Molecular Medicine (IMM), School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China. dding@sjtu.edu.cn.
Yu YangInstitute of Molecular Medicine (IMM), School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, 200127, China. yuyang@shsmu.edu.cn.
Renji Hospital · CNShanghai Jiao Tong University · CNShanghai Municipal Center For Disease Control Prevention · CNUniversity of Macau · MO

Funding

"Clinic Plus" Outstanding Project 2021ZYB009National Natural Science Foundation of China 22277072Shanghai Sailing Program 21YF1425700the National Research Programs of China 2022YFA1206500
6 · The paper itself

Abstract

The COVID-19 pandemic, which originated in Hubei, China, in December 2019, has had a profound impact on global public health. With the elucidation of the SARS-CoV-2 virus structure, genome type, and routes of infection, a variety of diagnostic methods have been developed for COVID-19 detection and surveillance. Although the pandemic has been declared over, we are still significantly affected by it in our daily lives in the post-pandemic era. Among the various diagnostic methods, nanomaterials, especially metallic nanomaterials, have shown great potential in the field of bioanalysis due to their unique physical and chemical properties. This review highlights the important role of metallic nanosensors in achieving accurate and efficient detection of COVID-19 during the pandemic outbreak and spread. The sensing mechanisms of each diagnostic device capable of analyzing a range of targets, including viral nucleic acids and various proteins, are described. Since SARS-CoV-2 is constantly mutating, strategies for dealing with new variants are also suggested. In addition, we discuss the analytical tools needed to detect SARS-CoV-2 variants in the current post-pandemic era, with a focus on achieving rapid and accurate detection. Finally, we address the challenges and future directions of metallic nanomaterial-based COVID-19 detection, which may inspire researchers to develop advanced biosensors for COVID-19 monitoring and rapid response to other virus-induced pandemics based on our current achievements.

Indexed as

COVID-19COVID-19 TestingHumansPandemicsSARS-CoV-2COVID-19DiagnosisNanomaterialsSurveillance

Identifiers

PMID37542245
PMCPMC10403867
OpenAlexW4385565520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.